MIM
FLNA

MetLife Investment Management’s Filana Therapeutics FLNA Stock Holding History

MetLife Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,699
Closed -$668K – 2850
2024
Q3 		$668K Hold
22,699
– – ﹤0.01% 1622
2024
Q2 		$280K Buy
22,699
+2,277
+11% +$48K ﹤0.01% 2040
2024
Q1 		$414K Hold
20,422
– – ﹤0.01% 1783
2023
Q4 		$460K Hold
20,422
– – ﹤0.01% 1742
2023
Q3 		$340K Hold
20,422
– – ﹤0.01% 1864
2023
Q2 		$501K Buy
20,422
+683
+3% +$16.4K ﹤0.01% 1690
2023
Q1 		$476K Hold
19,739
– – ﹤0.01% 1678
2022
Q4 		$583K Sell
19,739
-981
-5% -$35.3K ﹤0.01% 1539
2022
Q3 		$867K Hold
20,720
– – 0.01% 1268
2022
Q2 		$583K Sell
20,720
-1,092
-5% -$27.6K ﹤0.01% 1556
2022
Q1 		$810K Buy
21,812
+8,050
+58% +$341K 0.01% 1466
2021
Q4 		$601K Hold
13,762
– – ﹤0.01% 1414
2021
Q3 		$854K Hold
13,762
– – 0.01% 1205
2021
Q2 		$1.18M Buy
13,762
+1,087
+9% +$58.2K 0.01% 1083
2021
Q1 		$570K Sell
12,675
-3,221
-20% -$127K 0.01% 1450
2020
Q4 		$108K Buy
+15,896
New +$142K ﹤0.01% 2220

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

MetLife Investment Management's FLNA Position: Q4 2024 in Review

MetLife Investment Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 22,699 shares — an estimated $668K sold.

MetLife Investment Management first reported a position in FLNA in Q4 2020 and held it in 16 quarters. The position peaked at $1.18M in Q2 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • MetLife Investment Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 22,699 Filana Therapeutics shares in Q4 2024, an estimated $668K.
  • MetLife Investment Management first reported a position in Filana Therapeutics in Q4 2020 and held it in 16 quarters.
  • MetLife Investment Management's Filana Therapeutics position peaked at $1.18M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.